Hot Topic Discussion: The ADVANCE Study: Assessing Donor Variability And New Concepts in Eligibility (23EL-849) – Free for everyone!

Please note: AABB reserves the right to make updates to this program.

• Program Description

  Join principal investigators on the ADVANCE study (Assessing Donor Variability And New Concepts in Eligibility) to understand some of the key data that, along with data from TTIMS and other sources, helped to inform decision making for the recent FDA recommendations for assessing blood donor eligibility using a set of individual risk-based questions to reduce the risk of transfusion-transmitted HIV. An overview of the study findings will be followed by an opportunity for the audience to ask questions.

  Faculty

  • Barbee I. Whitaker, PhD, Lead General Health Scientist, Division of Analytics and Benefit Risk Assessment, Office of Biostatistics and Pharmacovigilance, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration
  • Brian Custer, PhD, MPH, Director Vitalant Research Institute, Senior Vice President Research and Scientific Programs, Vitalant, Adjunct Professor, Laboratory Medicine, UCSF
  • Sharon Carayiannis, BSMT(ASCP)HP, Vice President, Science and Practice, AABB

  Continuing Education Credit

  Continuing education credit will not be offered for this program.

  Register